SELECTIVITY OF ACTION CAN BE ACHIEVED WITH COMPOUNDS ACTING AT 2ND MESSENGER TARGETS

被引：6

作者：

CORDA, D

LUINI, A

GARATTINI, S

机构：

[1] IST RIC FARMACOL MARIO NEGRI,CONSORZIO MARIO NEGRI SUD NEUROENDOCRINOL LAB,I-66030 S MARIA IBARO,ITALY

[2] MARIO NEGRI INST PHARMACOL RES,I-20157 MILAN,ITALY

来源：

TRENDS IN PHARMACOLOGICAL SCIENCES | 1990年 / 11卷 / 12期

关键词：

D O I：

10.1016/0165-6147(90)90133-S

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：471 / 473

页数：3

共 12 条

[1] PRIMARY SEQUENCE OF CYCLIC-NUCLEOTIDE PHOSPHODIESTERASE ISOZYMES AND THE DESIGN OF SELECTIVE INHIBITORS [J].

BEAVO, JA ;

REIFSNYDER, DH .

TRENDS IN PHARMACOLOGICAL SCIENCES, 1990, 11 (04) :150-155

[2] BIOCHEMICAL SELECTIVITY OF ORAL VERSUS INTRAVENOUS ASPIRIN IN RATS - INHIBITION BY ORAL ASPIRIN OF CYCLOOXYGENASE ACTIVITY IN PLATELETS AND PRESYSTEMIC BUT NOT SYSTEMIC VESSELS [J].

CERLETTI, C ;

GAMBINO, MC ;

GARATTINI, S ;

DEGAETANO, G .

JOURNAL OF CLINICAL INVESTIGATION, 1986, 78 (01) :323-326

[3] SITE-SELECTIVE 8-CHLORO-CYCLIC ADENOSINE-3',5'-MONOPHOSPHATE AS A BIOLOGIC MODULATOR OF CANCER - RESTORATION OF NORMAL CONTROL MECHANISMS [J].

CHOCHUNG, YS .

JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1989, 81 (13) :982-987

[4] OVERVIEW OF CARDIOVASCULAR PHYSIOLOGIC AND PHARMACOLOGIC ASPECTS OF SELECTIVE PHOSPHODIESTERASE PEAK-III INHIBITORS [J].

EVANS, DB .

AMERICAN JOURNAL OF CARDIOLOGY, 1989, 63 (02) :A9-A11

[5]

HALLCHER LM, 1980, J BIOL CHEM, V255, P896

[6]

JAKEN S, 1981, CANCER RES, V41, P2175

[7]

LYALL RM, 1989, J BIOL CHEM, V264, P14503

[8] 2 G-PROTEIN ONCOGENES IN HUMAN ENDOCRINE TUMORS [J].

LYONS, J ;

LANDIS, CA ;

HARSH, G ;

VALLAR, L ;

GRUNEWALD, K ;

FEICHTINGER, H ;

DUH, QY ;

CLARK, OH ;

KAWASAKI, E ;

BOURNE, HR ;

MCCORMICK, F .

SCIENCE, 1990, 249 (4969) :655-659

[9]

OBRIAN CA, 1985, CANCER RES, V45, P2462

[10] ROLIPRAM, A NOVEL ANTIDEPRESSANT DRUG, REVERSES THE HYPOTHERMIA AND HYPOKINESIA OF MONOAMINE-DEPLETED MICE BY AN ACTION BEYOND POSTSYNAPTIC MONOAMINE RECEPTORS [J].

WACHTEL, H ;

SCHNEIDER, HH .

NEUROPHARMACOLOGY, 1986, 25 (10) :1119-1126

← 1 2 →